Anindita Banerjee

A phase 2a randomized, placebo-controlled study to evaluate the efficacy and safety of the oral Janus kinase inhibitors ritlecitinib and brepocitinib in alopecia areata: 24-week results

Brett King, Emma Guttman‐Yassky, Elena Peeva et al. · Journal of the American Academy of Dermatology · 2021 · 184 citations · Full text

Backgroundalopecia Areata, Pharmacology, Clinical Trials +10

Randomised trial and open-label extension study of an anti-interleukin-6 antibody in Crohn’s disease (ANDANTE I and II)

Silvio Danese, Séverine Vermeire, Paul Hellstern et al. · Gut · 2017 · 174 citations · Full text

Oxidative DNA damage preventive activity and antioxidant potential of plants used in Unani system of medicine

Mehar Darukhshan Kalim, Dipto Bhattacharyya, Anindita Banerjee et al. · BMC Complementary and Alternative Medicine · 2010 · 170 citations · Full text

Efficacy and safety of oral ritlecitinib for the treatment of active nonsegmental vitiligo: A randomized phase 2b clinical trial

Khaled Ezzedine, Elena Peeva, Yuji Yamaguchi et al. · Journal of the American Academy of Dermatology · 2022 · 126 citations · Full text

Translational Medicine, Active Nonsegmental Vitiligo, Pharmacology +5

Ritlecitinib and brepocitinib demonstrate significant improvement in scalp alopecia areata biomarkers

Emma Guttman‐Yassky, Ana B. Pavel, Aisleen Diaz et al. · Journal of Allergy and Clinical Immunology · 2021 · 91 citations · Full text